MedTrace Logo

Prognosis of Low-grade Endometrial Stromal Sarcoma

NCT05310318 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-04-04

No results posted yet for this study

Summary

This study is to investigate the survival outcomes and fertility outcomes in patients with uterine low-grade endometrial stromal sarcoma (LGESS) treated in Peking Union Medical College Hospital. All primary and recurrent LGESS patients will be enrolled. The study will collect retrospectively data consisting of epidemiological characteristics, surgical, medical treatment and adjuvant therapy. Details about recurrence, mortality, pregnancy and obstetrical outcomes are also followed as primary endpoints. Fertility-sparing procedures, including uterine-sparing and ovary-sparing surgeries will be recorded specifically.

Conditions

  • Low Grade Endometrial Stromal Sarcoma of Uterus (Diagnosis)
  • Fertility-sparing Surgery
  • Survival Outcomes
  • Fertility Outcomes
  • Recurrence
  • Hormone Therapy
  • Adjuvant Therapy

Interventions

PROCEDURE

Surgical treatment with and without fertility-sparing procedures

Patients accepted surgeries for LGESS and relevant adjuvant therapy if indicated.

Sponsors & Collaborators

  • Lei Li

    lead OTHER

Principal Investigators

  • Lei Li, M.D. · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-26
Primary Completion
2024-03-26
Completion
2025-03-26

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05310318 on ClinicalTrials.gov